Is it time for geriatricians to get on board with lecanemab? Jason Karlawish and Ken Covinsky
GeriPal
DECEMBER 15, 2022
In an article in the NEJM (a published article this time, wonder of wonders!) Tell me how your illness has impacted your relationships with others, your healthcare team, your family, friends, your beliefs, your values, your preferences. But wait, there’s a shiny new anti-amyloid drug, lecanemab! (No Oh my gosh.
Let's personalize your content